相关实验视频

Updated: Jul 3, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

皮肤肌炎亚型的临床特征和症状进展:对前数据库的回顾性分析

Rachita Pandya¹, Julianne Kleitsch¹, Darosa Lim¹

¹Dermatology, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania; Department of Dermatology, Perelman Center for Advanced Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Journal of the American Academy of Dermatology

|February 11, 2024

概括

经典皮肤肌炎 (DM) 通常会发展为肌病后性DM (PmDM),许多人保留中度至严重的皮肤疾病. 临床 Amyopathic DM (CADM) 很少发展为肌肉参与,皮肤疾病的严重程度可能预测这种变化.

科学领域:

皮肤病学皮肤病学
类风湿病学类风湿病学
免疫学免疫学免疫学

背景情况:

经典皮肤肌炎 (DM) 和临床 Amyopathic DM (CADM) 疾病特征是已知的,但进展模式的理解较少.
对DM和CADM亚型的纵向跟踪对于了解疾病演变至关重要.

研究的目的:

在经典的DM和CADM患者中纵向跟踪和描述疾病进展.
确定影响亚型转换和疾病严重程度随时间推移的因素.

主要方法:

对从269名DM患者前性收集的数据进行了回顾性审查.
使用纵向数据库分析疾病特征和亚型变化.

主要成果:

百分之四十的经典DM患者过渡到后肌病性DM (PmDM).
皮肤皮质神经炎患者的皮肤皮质神经炎疾病区域和严重性指数 (CDASI-A) 活动得分中位数低于经典的DM,但许多患者保留了显著的皮肤活动.
5%的CADM患者患有肌肉干扰,往往与较轻的先前皮肤疾病.

结论:

经典的DM往往会发展为PmDM,肌肉持续,皮肤疾病往往很严重.
患有CADM的肌肉疾病的风险很低,基线皮肤疾病的严重程度可能预测这种进展.
了解DM亚型的进展是定制患者管理的关键.

关键词:

氨基病性皮肤肌肉学炎这是一种自身免疫性疾病.经典的皮肤肌肉炎.结合组织疾病结合组织疾病皮肤肌肉炎 (dermatomyositis) 是一种疾病.医学皮肤病医学皮肤病学

更多相关视频

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease

Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease

Published on: December 18, 2016

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

相关概念视频

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...